Koninklijke Philips (NYSE:PHG) Given Consensus Rating of "Moderate Buy" by Analysts

Shares of Koninklijke Philips (NYSE:PHG - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the five research firms that are presently covering the company, Marketbeat.com reports. Two analysts have rated the stock with a hold recommendation, two have assigned a buy recommendation and one has given a strong buy recommendation to the company.

Several equities research analysts have issued reports on PHG shares. StockNews.com upgraded Koninklijke Philips from a "hold" rating to a "buy" rating in a report on Saturday, March 8th. Sanford C. Bernstein raised shares of Koninklijke Philips from a "hold" rating to a "strong-buy" rating in a report on Tuesday, March 18th. BNP Paribas upgraded shares of Koninklijke Philips from a "neutral" rating to an "outperform" rating in a research note on Tuesday, February 25th. Finally, UBS Group raised shares of Koninklijke Philips from a "neutral" rating to a "buy" rating in a research report on Thursday, February 20th.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the business. State Street Corp grew its position in shares of Koninklijke Philips by 1.0% during the third quarter. State Street Corp now owns 82,518 shares of the technology company's stock worth $2,809,000 after acquiring an additional 844 shares during the last quarter. Wilmington Savings Fund Society FSB acquired a new position in Koninklijke Philips in the third quarter worth approximately $54,000. JPMorgan Chase & Co. lifted its holdings in shares of Koninklijke Philips by 315.0% during the third quarter. JPMorgan Chase & Co. now owns 245,729 shares of the technology company's stock valued at $8,040,000 after purchasing an additional 186,520 shares during the last quarter. GAMMA Investing LLC lifted its stake in Koninklijke Philips by 6.3% during the fourth quarter. GAMMA Investing LLC now owns 10,963 shares of the technology company's stock valued at $278,000 after buying an additional 648 shares in the last quarter. Finally, Bar Harbor Wealth Management grew its position in Koninklijke Philips by 2.1% during the 4th quarter. Bar Harbor Wealth Management now owns 308,157 shares of the technology company's stock worth $7,803,000 after purchasing an additional 6,281 shares in the last quarter. 13.67% of the stock is currently owned by institutional investors.

Koninklijke Philips Stock Up 1.0 %

NYSE:PHG traded up $0.25 during mid-day trading on Tuesday, hitting $24.71. The company had a trading volume of 584,074 shares, compared to its average volume of 887,573. The business has a fifty day simple moving average of $25.15 and a 200-day simple moving average of $26.49. The firm has a market capitalization of $23.23 billion, a price-to-earnings ratio of -29.42, a PEG ratio of 0.82 and a beta of 0.81. Koninklijke Philips has a 1 year low of $19.90 and a 1 year high of $32.91. The company has a current ratio of 1.23, a quick ratio of 0.74 and a debt-to-equity ratio of 0.59.

Koninklijke Philips (NYSE:PHG - Get Free Report) last posted its quarterly earnings data on Wednesday, February 19th. The technology company reported $0.54 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.55 by ($0.01). The firm had revenue of $5.38 billion for the quarter, compared to analysts' expectations of $5.10 billion. Koninklijke Philips had a negative net margin of 3.88% and a positive return on equity of 10.85%. Equities analysts forecast that Koninklijke Philips will post 1.63 earnings per share for the current fiscal year.

Koninklijke Philips Cuts Dividend

The firm also recently disclosed an annual dividend, which will be paid on Friday, June 6th. Shareholders of record on Tuesday, May 13th will be issued a $0.886 dividend. This represents a yield of 2.9%. The ex-dividend date is Tuesday, May 13th. Koninklijke Philips's dividend payout ratio is presently -89.29%.

About Koninklijke Philips

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.